2LKI

Solution NMR structure of holo acyl carrier protein NE2163 from nitrosomonas europaea. Northeast structural genomics consortium target NET1.

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCO	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
2	3D HNCA	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
3	3D CBCA(CO)NH	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
4	3D HBHA(CO)NH	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
5	3D HCCH-TOCSY	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
6	3D HCCH-TOCSY	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
7	3D 1H-15N NOESY	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
8	3D 1H-13C NOESY aliphatic	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
9	3D 1H-13C NOESY aromatic	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
10	3D HNCACB	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
11	3D C(CO)NH	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298
12	3D H(CCO)NH	1.0 mM [U-13C; U-15N] protein, 10 mM MOPS, 450 mM sodium chloride, 10 uM ZnSO4, 10 mM DTT, 0.01 % NaN3, 1 mM benzamidine	90% H2O/10% D2O	450	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
restrained molecular dynamics		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	peak picking	Sparky		Goddard
3	chemical shift assignment	FMC		Lemak,Steren,Llinas, Arrowsmith
4	data analysis	TALOS		Cornilescu, Delaglio and Bax
5	validation	PSVS		Bhattacharya and Montelione
6	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
7	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.